Abortion
FDA delays publication of mifepristone safety review until March
A court filing indicates the Food and Drug Administration will not release its safety review of the abortion medication mifepristone until March and does not plan to impose additional restrictions on the drug before…
1 source2 claims checked4h ago
2 unverifiable
Biblical perspectiveINSUFFICIENT CONTEXT
Full analysis